The findings suggest that IL-18 promotor SNPs could be useful predictive markers to optimize prophylaxis against CMV infection in kidney transplant recipients, although large, controlled, multicentric studies are needed to confirm them. The gene discussed is IL18; the disease is cytomegalovirus infection.